In this article, we discuss the 15 stocks that could mint millionaires in 2026.
For more than a century, investing in the stock market in the United States has represented one of the most accessible paths to generating substantial wealth for the amateur investor, with a long and storied history that shows disciplined, long-term equity investing can turn ordinary savers into millionaires. Some important contributing factors to this are time, compound returns, diversification, and staying invested through market turbulence. A recent finance commentary by Fisher Investments, published by news agency Reuters, stressed the importance of compound returns for investors, arguing that how long a person invests matters more than the time at which the stock was bought.
Equity also remains a major driver of household wealth. In the US, for instance, Reuters reports that $5.51 trillion of the $7.09 trillion increase in net household wealth in the second quarter of 2025 stemmed from rising equity prices. This underscores how, for many investors, the stock market is the principal vehicle for wealth accumulation. Indeed, the affluent tend to have a higher equity allocation, which magnifies their upside over multi-decade investing horizons. The shift in investor flows hints at where opportunities may lie. According to Reuters, investors have pulled $152 billion from US growth funds in the first nine months of 2025, even as the S&P 500 hit record highs, signaling rotation toward undervalued sectors and small caps.
Our Methodology
For this article, we used stock screeners to identify stocks with more than $2 billion in market capitalization that have a revenue growth and EPS growth rate of above 15%, as well as analysts’ upside potential of over 50% as of December 18. The top fifteen companies were selected and ranked in ascending order of their upside potential. These stocks are also popular among hedge funds, according to Insider Monkey’s database of Q3 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
Stocks That Could Mint Millionaires in 2026
15. Dutch Bros Inc. (NYSE:BROS)
Number of Hedge Fund Holders: 46
Next Year Revenue Growth: 25%
Next Year EPS Growth: 32%
Analyst Upside: 51%
Dutch Bros Inc. (NYSE:BROS) is one of the stocks that could mint millionaires in 2026.
On December 17, KeyBanc analyst Christopher Carril initiated coverage of Dutch Bros Inc. (NYSE:BROS) stock with an Overweight rating and $77 price target. In an investor note, the analyst noted that the company represented one of the most compelling growth stories, driven by mid-teens unit growth, and while shares had outperformed peers in 2025, the performance had not fully reflected strong fundamentals, as sentiment around the fast casual segment remained largely negative. The company’s sales drivers in 2026 were highly visible, including an expanded food menu and growth in mobile ordering, the analyst added.
On November 5, the company posted earnings for the third quarter of 2025, reporting earnings per share of $0.19, beating estimates by $0.02. The revenue over time was $423.58 million, up 25.2% year-on-year and beating expectations by $9.98 million. It also updated guidance numbers for the 2025 fiscal year. Total revenues are now projected to be between approximately $1.61 billion and $1.615 billion, versus consensus estimates of $1.60 billion. Same shop sales growth is now expected to be approximately 5%.
Dutch Bros Inc. (NYSE:BROS) operates and franchises drive-thru shops in the United States.
14. ADMA Biologics, Inc. (NASDAQ:ADMA)
Number of Hedge Fund Holders: 42
Next Year Revenue Growth: 26%
Next Year EPS Growth: 56%
Analyst Upside: 59%
ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the stocks that could mint millionaires in 2026.
ADMA Biologics, Inc. (NASDAQ:ADMA) markets BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency, and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics.
In earnings for the third quarter of 2025, the firm provided updated guidance, noting that for 2025, total revenue was now expected to be $510 million, up from prior guidance of more than $500 million. The 2025 adjusted net income was also modestly adjusted to $158 million due to a higher effective tax rate.
ADMA Biologics, Inc. (NASDAQ:ADMA) is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
13. Wingstop Inc. (NASDAQ:WING)
Number of Hedge Fund Holders: 39
Next Year Revenue Growth: 19%
Next Year EPS Growth: 28%
Analyst Upside: 62%
Wingstop Inc. (NASDAQ:WING) is one of the stocks that could mint millionaires in 2026.
On December 9, RBC Capital analyst Logan Reich raised the price target on Wingstop Inc. (NASDAQ:WING) stock to $350 from $300 and kept an Outperform rating on the shares. In an investor note, the analyst noted that the company’s best-in-class franchisee ROIC should support double-digit unit growth while adding that Wingstop had a long runway in the US and was still in the early stages of international expansion.
Wingstop Inc. (NASDAQ:WING) posted earnings for the third quarter of 2025 in early November, reporting earnings per share of $1.02, beating estimates by $0.11. The revenue over time was $175.7 million, up 8.1% year-on-year but missing expectations by $9.62 million. The firm also provided updated guidance numbers for 2025, saying it expected approximately 3% to 4% decline for domestic same-store sales growth, 475 to 485 global net new units, and SG&A of between $131 and $132 million.
Wingstop Inc. (NASDAQ:WING) franchises and operates restaurants under the Wingstop brand.
12. Clearwater Analytics Holdings, Inc. (NYSE:CWAN)
Number of Hedge Fund Holders: 33
Next Year Revenue Growth: 30%
Next Year EPS Growth: 31%
Analyst Upside: 66%
Clearwater Analytics Holdings, Inc. (NYSE:CWAN) is one of the stocks that could mint millionaires in 2026.
Latest reports, published by news agency Reuters, indicate that Thoma Bravo has made an offer for the company. Previous reports had held that private equity firms Warburg Pincus and Permira were in talks to acquire Clearwater. News outlet Bloomberg has also reported that Clearwater is considering a potential sale. On December 9, Reuters reported that activist investor Starboard Value had taken a nearly 5% stake in Clearwater Analytics and wanted the technology company to boost its share price and run a robust sales process with independent advisers.
Clearwater Analytics Holdings, Inc. (NYSE:CWAN) posted earnings for the third quarter of 2025 in early November, reporting earnings per share of $0.14, in-line with estimates. The revenue over time was $205.1 million, up 77.1% compared to the revenue over the same period last year and beating analyst expectations by $1.5 million.
Clearwater Analytics Holdings, Inc. (NYSE:CWAN) develops and provides a Software-as-a-Service (SaaS) solution.
11. Corcept Therapeutics Incorporated (NASDAQ:CORT)
Number of Hedge Fund Holders: 28
Next Year Revenue Growth: 38%
Next Year EPS Growth: 103%
Analyst Upside: 76%
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the stocks that could mint millionaires in 2026.
On December 16, UBS analyst Ashwani Verma initiated coverage of Corcept Therapeutics Incorporated (NASDAQ:CORT) stock with a Neutral rating and $95 price target. In an investor note, the analyst cited valuation for the Neutral rating, with the shares up 64% year-to-date. Per the analyst, the stock was already pricing in both the continued growth in hypercortisolism and Corcept’s new launch opportunity in platinum-resistant ovarian cancer.
In early November, the company posted earnings for the third quarter of 2025, reporting earnings per share of $0.16, beating market estimates by $0.02. The revenue over the period was more than $207 million, up close to 14% compared to the revenue over the same period last year and missing analyst expectations by close to $11 million. The firm also modified 2025 revenue guidance of $800 to $850 million versus the $852 million consensus.
Corcept Therapeutics Incorporated (NASDAQ:CORT) engages in the discovery and development of medications for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
10. Upstart Holdings, Inc. (NASDAQ:UPST)
Number of Hedge Fund Holders: 37
Next Year Revenue Growth: 27%
Next Year EPS Growth: 51%
Analyst Upside: 78%
Upstart Holdings, Inc. (NASDAQ:UPST) is one of the stocks that could mint millionaires in 2026.
The fintech firm, founded in 2012, has originated about $48 billion in loans, a small share of the overall lending market. It partners with over 100 banks and credit unions and offers personal loans, auto refinancing, and home equity lines of credit—together representing a multi-trillion-dollar opportunity. A key innovation is using artificial intelligence to replace traditional FICO credit scoring, analyzing more than 2,500 borrower variables to better assess credit risk and reduce defaults.
In early November, the firm announced a new 12-month forward-flow agreement with alternative investment firm Castlelake. Under the deal, the latter has agreed to purchase up to $1.5 billion in consumer loans originated on the Upstart platform. This is the third such deal between the two companies, with earlier ones being $4 billion and $1.2 billion purchase agreements.
Upstart Holdings, Inc. (NASDAQ:UPST) operates a cloud-based artificial intelligence (AI) lending platform in the United States.
9. Alkami Technology, Inc. (NASDAQ:ALKT)
Number of Hedge Fund Holders: 14
Next Year Revenue Growth: 25%
Next Year EPS Growth: 80%
Analyst Upside: 79%
Alkami Technology, Inc. (NASDAQ:ALKT) is one of the stocks that could mint millionaires in 2026.
According to a report by news agency Reuters, activist investor Jana Partners took a stake in Alkami Technology, Inc. (NASDAQ:ALKT) in the third quarter. News platform Bloomberg reported on December 9 that Partners thinks the banking firm was undervalued and should explore a sale to a rival or private equity firm. Scott Ostfeld, a managing member at Jana, said at the Bloomberg Activism Forum in New York that Alkami Technology, Inc. (NASDAQ:ALKT) was trading at a substantial discount after shares had plunged close to 40% this year. Per the activist investor, Alkami is an attractive target for PE given its organic top-line growth and high customer retention rate.
For the fourth quarter of 2025, Alkami Technology, Inc. (NASDAQ:ALKT) expects revenue in the range of $119.6 million to $121.1 million and adjusted EBITDA in the range of $16.1 million to $17.1 million. For the full year 2025, the firm has set revenue guidance at $442.5 million to $444 million, with full year adjusted EBITDA guidance of $56 million to $57 million.
Alkami Technology, Inc. (NASDAQ:ALKT) provides cloud-based digital banking solutions in the United States.
8. Grindr Inc. (NYSE:GRND)
Number of Hedge Fund Holders: 29
Next Year Revenue Growth: 23%
Next Year EPS Growth: 30%
Analyst Upside: 91%
Grindr Inc. (NYSE:GRND) is one of the stocks that could mint millionaires in 2026.
Late last month, the company announced that it would cease engagement over a take-private offer from large shareholders Ray Zage and James Lu to buy the company for $18 per share in cash. A special committee of the board made the determination due to continued uncertainty as to the financing for the proposed offer, according to a statement.
On November 6, Grindr Inc. (NYSE:GRND) posted earnings for the third quarter, reporting a revenue of $116 million, beating analyst expectations by $2.69 million. The net income during the time was $31 million. While providing updated guidance, the company raised full year 2025 adjusted EBITDA outlook to between $191 million and $193 million, implying a margin greater than 43%, as management reaffirmed its revenue growth outlook of 26% or greater.
Grindr Inc. (NYSE:GRND) operates social network and dating applications for the lesbian, gay, bisexual, transgender, and queer (LGBTQ) communities worldwide.
7. Remitly Global, Inc. (NASDAQ:RELY)
Number of Hedge Fund Holders: 38
Next Year Revenue Growth: 21%
Next Year EPS Growth: 161%
Analyst Upside: 94%
Remitly Global, Inc. (NASDAQ:RELY) is one of the stocks that could mint millionaires in 2026.
In early November, the company posted earnings for the third quarter of 2025, reporting earnings per share of $0.04, beating estimates by $0.01. The revenue over the period was $419.49 million, up 24.7% year-on-year and beating estimates by $5.76 million. For the full fiscal year, the firm expects the total revenue to be in the range of $1.619 billion to $1.621 billion, representing a growth rate of 28% year over year.
Matt Oppenheimer, the chief of Remitly Global, Inc. (NASDAQ:RELY), recently provided a preliminary outlook for the medium-term financial targets for 2028, as well with revenue expected to be in a range of $2.6 billion to $3 billion. Adjusted EBITDA is expected to be between $575 million and $600 million, reflecting a 20%-22% margin.
Remitly Global, Inc. (NASDAQ:RELY) engages in the provision of digital financial services in the United States, Canada, and internationally.
6. Braze, Inc. (NASDAQ:BRZE)
Number of Hedge Fund Holders: 34
Next Year Revenue Growth: 17%
Next Year EPS Growth: 24%
Analyst Upside: 96%
Braze, Inc. (NASDAQ:BRZE) is one of the stocks that could mint millionaires in 2026.
On December 17, BTIG assumed coverage of Braze, Inc. (NASDAQ:BRZE) stock with a Buy rating and $45 price target. The analyst told investors in a research note that Q3 marked another quarter of growth reacceleration, improvements in in-period dollar-based net retention rate, heightened sales productivity, and continued margin expansion for the firm.
On December 9, Braze, Inc. (NASDAQ:BRZE) announced earnings for the third quarter, reporting earnings per share of $0.06, missing market estimates by $0.01. The revenue over the period was $190 million, up over 25% compared to the revenue over the same period last year and beating estimates by $6.7 million.
Braze, Inc. (NASDAQ:BRZE) operates a customer engagement platform that provides interactions between consumers and brands worldwide.
5. Klaviyo, Inc. (NYSE:KVYO)
Number of Hedge Fund Holders: 48
Next Year Revenue Growth: 22%
Next Year EPS Growth: 26%
Analyst Upside: 100%
Klaviyo, Inc. (NYSE:KVYO) is one of the stocks that could mint millionaires in 2026.
On December 15, BTIG analyst Nick Altmann initiated coverage of Klaviyo, Inc. (NYSE:KVYO) stock with a Buy rating and $40 price target. Since its IPO, the company has remained one of the fastest-growing publicly traded software companies despite reaching scale, the analyst told investors in a research note. Concerns over retail/e-commerce and lack of margin improvement have resulted in shares having a more muted performance, but recent checks were constructive and suggest a ripe opportunity for cross-selling customers, BTIG added.
On November 5, the firm posted earnings for the third quarter of 2025, reporting earnings per share of $0.18, beating expectations by $0.04. The revenue over the period was $310.88 million, up 32.2% year-on-year and beating estimates by $11.04 million. The firm also outlined a 21–22% revenue growth target for 2026 amid rapid AI product adoption and international momentum.
Klaviyo, Inc. (NYSE:KVYO) provides a software-as-a-service platform in the United States, the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
4. Alvotech (NASDAQ:ALVO)
Number of Hedge Fund Holders: 12
Next Year Revenue Growth: 42%
Next Year EPS Growth: 300%
Analyst Upside: 112%
Alvotech (NASDAQ:ALVO) is one of the stocks that could mint millionaires in 2026.
The firm recently launched a $100 million offering of senior unsecured convertible notes due 2030 and reaffirmed its 2025 outlook while providing initial guidance for 2026. In 2026, Alvotech anticipates total revenues in the range of $650-$700 million, reflecting continued sales growth. Adjusted EBITDA is expected to increase to $180-$220 million, supported by higher volumes of commercialized products and launches of newly approved products in Europe and Japan.
On November 12, Alvotech (NASDAQ:ALVO) posted third-quarter results, posting earnings per share of $0.47, beating estimates by $0.49. Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year. Product and service revenue increased by 85%, to $237 million in the first nine months compared to the same period last year, per the firm.
Alvotech (NASDAQ:ALVO) develops and manufactures biosimilar medicines for patients worldwide.
3. The GEO Group, Inc. (NYSE:GEO)
Number of Hedge Fund Holders: 47
Next Year Revenue Growth: 20%
Next Year EPS Growth: 109%
Analyst Upside: 123%
The GEO Group, Inc. (NYSE:GEO) is one of the stocks that could mint millionaires in 2026.
The GEO Group, Inc. (NYSE:GEO) was recently mentioned in a letter sent earlier this week to the inspectors general for the Department of Homeland Security and the Department of Defense by a group of Democrats led by Massachusetts Senator Elizabeth Warren and Maryland Representative Jamie Raskin, with the lawmakers expressing concern that immigration contractors were potentially receiving lucrative, no-bid contracts because of their proximity to Trump administration officials.
In early November, the firm announced earnings for the third quarter, reporting earnings per share of $0.25, beating estimates by $0.02. The revenue over the period was $682.34 million, up 13.1% year-on-year and beating expectations by $16.53 million.
The GEO Group, Inc. (NYSE:GEO) owns, leases, operates, and manages secure facilities, processing centers, and community-based reentry facilities in the United States, Australia, the United Kingdom, and South Africa.
2. QXO, Inc. (NYSE:QXO)
Number of Hedge Fund Holders: 65
Next Year Revenue Growth: 56%
Next Year EPS Growth: 42%
Analyst Upside: 140%
QXO, Inc. (NYSE:QXO) is one of the stocks that could mint millionaires in 2026.
QXO, Inc. (NYSE:QXO) has received bullish calls from analysts. For example, on December 3, Morgan Stanley analyst Christopher Snyder maintained a Buy rating on the stock with a price target of $35. In a note to investors, Snyder underlined that the company’s strategic focus on improving the performance of acquired businesses, particularly BECN, and executing on a robust M&A pipeline positioned it well for future success.
In late October, the firm posted earnings for the third quarter of 2025, reporting earnings per share of $0.14, beating estimates by $0.02. The revenue over time was in excess of $2.7 billion, beating expectations by $20 million.
QXO, Inc. (NYSE:QXO) distributes roofing, waterproofing, and other building products in the United States.
1. Atlassian Corporation (NASDAQ:TEAM)
Number of Hedge Fund Holders: 60
Next Year Revenue Growth: 19%
Next Year EPS Growth: 23%
Analyst Upside: 196%
Atlassian Corporation (NASDAQ:TEAM) is one of the stocks that could mint millionaires in 2026.
On December 17, BTIG analyst Allan Verkhovski initiated coverage of Atlassian Corporation (NASDAQ:TEAM) stock with a Buy rating and $220 price target. In a note to investors, the analyst noted that the AI disruption risk was overblown, with the shares down roughly 42% over the past year, and cloud revenue guidance was de-risked with the potential to grow in the mid-20 percentage range for the rest of FY26.
In earnings for the first fiscal quarter, released in late October, Atlassian Corporation (NASDAQ:TEAM) outlined updated guidance numbers. The firm raised its cloud revenue outlook by 1.5 points to 22.5% year-over-year for the 2026 fiscal year. The company also reiterated its long-term 20% CAGR growth rate target, with CEO Cannon-Brookes stating that the firm felt incredible confidence in the ability to deliver that.
Atlassian Corporation (NASDAQ:TEAM) provides collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.
While we acknowledge the potential of TEAM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TEAM and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: Goldman Sachs Value Stocks: 10 Stocks to Buy and 14 Best Precious Metals Stocks to Buy Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
